Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 5.27Quest Laboratories demonstrates a mixed financial performance. Profitability stands out as a significant strength, driven by healthy margins and returns on capital, equity, and assets. Solvency also appears strong, indicating a conservative approach to debt. However, the company faces challenges in liquidity and efficiency, with turnover ratios suggesting potential issues in managing assets and liabilities. Growth metrics reveal a concerning contraction in revenue, EPS, and asset growth in the latest financial year. While coverage ratios are adequate, the absence of dividend coverage raises concerns. The company's strong profitability and solvency are offset by liquidity and efficiency issues. The recent negative growth trends in revenue and earnings are a significant concern that needs attention.
Health Score : 5.27Quest Laboratories demonstrates a mixed financial performance. Profitability stands out as a significant strength, driven by healthy margins and returns on capital, equity, and assets. Solvency also appears strong, indicating a conservative approach to debt. However, the company faces challenges in liquidity and efficiency, with turnover ratios suggesting potential issues in managing assets and liabilities. Growth metrics reveal a concerning contraction in revenue, EPS, and asset growth in the latest financial year. While coverage ratios are adequate, the absence of dividend coverage raises concerns. The company's strong profitability and solvency are offset by liquidity and efficiency issues. The recent negative growth trends in revenue and earnings are a significant concern that needs attention.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
9.35
Industry Median
30.91
Small Cap Median
28.64
P/E RATIO
9.34
P/B RATIO
1.45
Industry Median
3.69
Small Cap Median
3.11
P/S RATIO
1.24
Industry Median
3.74
Small Cap Median
3.02
Others
PEG RATIO
0.00
EV/EBITDA RATIO
6.65
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹85.65 as on Sep 1, 2026.
Growth Score : 3.20Growth metrics indicate significant challenges for Quest Laboratories, with declines in revenue, EPS, and asset growth. Strong operating profit growth is overshadowed by these contractions. The company needs to address the factors causing these declines to ensure sustainable growth and maintain its competitive position.
Revenue Growth RatePoorOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthPoorAsset Growth RatePoorNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 96.67 | 5.08 | 33.87 | 25.3 | 7.69 |
| Operating Profit Growth Rate | 500 | 33.33 | 100 | 0 | 12.5 |
| Earnings Per Share (EPS) Growth | -2.01 | 10.75 | |||
| Asset Growth Rate | 94.44 | 34.29 | 29.79 | 100 | -9.02 |
| Net Income Growth Rate | 300 | 25 | 100 | 40 | 7.14 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
No Peer Data Is Available at This Moment.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Quest Laboratories Ltd. is an Indian pharmaceutical manufacturer specializing in a wide range of pharmaceutical formulations. The company focuses on sterile liquid dosage forms, ophthalmic products, dry powder injections, and general oral solids for both domestic and export markets, including contract manufacturing.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Quest Laboratories Ltd's P/E ratio (TTM) is 9.35, compared to the industry median of 30.91 and large cap median of 28.64.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Quest Laboratories Ltd's P/B ratio is 1.45, compared to the industry median of 3.69 and large cap median of 3.11.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Quest Laboratories Ltd's P/S ratio is 1.24, compared to the industry median of 3.74 and large cap median of 3.02.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Quest Laboratories Ltd's PEG ratio is 1.75.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Quest Laboratories Ltd's EV/EBITDA ratio is 6.65.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Quest Laboratories Ltd's ROE is 15.62%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Quest Laboratories Ltd's ROA is 16.22%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Quest Laboratories Ltd's ROCE is 18%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Quest Laboratories Ltd's operating margin is 16.07%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Quest Laboratories Ltd's net margin is 13.39%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Quest Laboratories Ltd's current ratio is 6.09.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Quest Laboratories Ltd's debt-to-equity ratio is 0.01.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Quest Laboratories Ltd's interest coverage ratio is 10.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Quest Laboratories Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Quest Laboratories Ltd's EPS is 10.75.
(Source line: "Ratios as of 26 Sept 2026, based on last traded price of ₹85.65. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2007 (as Quest Laboratories Private Limited)
Headquarters: Indore, Madhya Pradesh
Core Offerings: Sterile liquid dosage forms, Sterile ophthalmic products, Sterile dry powder injections, General oral solids, Oral liquid syrups/suspensions
Stock Listing: NSE (QUESTLAB), BSE ({bse})
Promoter: Quest Pharma International Private Limited / Bharija Family (Satish Bharija, Basant Bharija, Dhwanil Bharija)
Incorporated in 2007 as Quest Laboratories Private Limited, the company commenced its manufacturing operations in 2009. Over the years, it expanded its product portfolio and manufacturing capabilities for various pharmaceutical formulations. The company converted to a public limited company in 2023 and successfully launched its IPO in March 2024, listing its shares on NSE Emerge.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Pharmaceutical Formulations Manufacturing | 100% | Operating Profit |
Pharmaceutical Formulations: Engaged in the manufacturing of a diverse range of pharmaceutical formulations, including antibiotics, anti-malaria, anti-acid, anti-allergic, anti-fungal, and more. This segment serves both the domestic and export markets, encompassing various dosage forms.
Specialized Dosage Forms: Focuses on sterile liquid dosage forms (e.g., injections), sterile ophthalmic products (e.g., eye drops), sterile dry powder injections, and general oral solids (e.g., tablets, capsules).
Mr. Satish Bharija serves as the Chairman & Managing Director. He is one of the promoters and has extensive experience in the pharmaceutical industry, guiding the company's strategic vision and operations.
No major subsidiaries reported.
Initial Public Offering (IPO) in March 2024, with shares listed on NSE Emerge.
The Quest Laboratories Ltd share price today is ₹85.65 on NSE (QUESTLAB), as of 26 Sept 2026.
As of 26 Sept 2026, Quest Laboratories Ltd share price is ₹85.65, with previous close ₹85.65. Today's range is ₹85.65 to ₹85.65. The 52-week range is ₹N/A to ₹N/A.
As of today, Quest Laboratories Ltd's market cap is ₹138.75 crore (Small Cap).
Quest Laboratories Ltd's current P/E ratio is 9.35, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 38.20.
Quest Laboratories Ltd's current P/B ratio is 1.45.
Quest Laboratories Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Quest Laboratories Ltd's EPS (TTM) is ₹10.75.
Quest Laboratories Ltd. is an Indian pharmaceutical manufacturer specializing in a wide range of pharmaceutical formulations. The company focuses on sterile liquid dosage forms, ophthalmic products, dry powder injections, and general oral solids for both domestic and export markets, including contract manufacturing.
Quest Laboratories Ltd is promoted by Quest Pharma International Private Limited / Bharija Family (Satish Bharija, Basant Bharija, Dhwanil Bharija), holding 66.78% as of 26 Sept 2026.
Quest Laboratories Ltd is listed on NSE (QUESTLAB) and BSE ({bse}). Its next quarterly results are expected on August 2024 (expected for Q1 FY25 results).
Cash Earnings Per Share (Cash EPS)
